awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41670949-1B08C924-4DF2-4BE1-8659-F201B914A403
Q41670949-1B08C924-4DF2-4BE1-8659-F201B914A403
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41670949-1B08C924-4DF2-4BE1-8659-F201B914A403
Integrins as Therapeutic Targets: Successes and Cancers.
P2860
Q41670949-1B08C924-4DF2-4BE1-8659-F201B914A403
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41670949-1B08C924-4DF2-4BE1-8659-F201B914A403
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0266b0f1a7343425d62edcb4a027c1c3c4d48135
P2860
Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial.